SIEMENS HEALTHINEERS AG (SHL.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:SHL - DE000SHL1006 - Common Stock
42.53 EUR
+0.35 (+0.83%)
Overall SHL gets a fundamental rating of 5 out of 10. We evaluated SHL against 63 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of SHL while its profitability can be described as average. SHL has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
SHL had positive earnings in the past year.
In the past year SHL had a positive cash flow from operations.
SHL had positive earnings in each of the past 5 years.
SHL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
SHL's Return On Assets of 4.83% is fine compared to the rest of the industry. SHL outperforms 65.08% of its industry peers.
SHL has a Return On Equity of 11.88%. This is in the better half of the industry: SHL outperforms 71.43% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.65%, SHL is in the better half of the industry, outperforming 65.08% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SHL is below the industry average of 9.33%.
The last Return On Invested Capital (7.65%) for SHL is above the 3 year average (6.28%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.83% | ||
| ROE | 11.88% | ||
| ROIC | 7.65% |
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
1.3 Margins
With a decent Profit Margin value of 9.17%, SHL is doing good in the industry, outperforming 66.67% of the companies in the same industry.
SHL's Profit Margin has been stable in the last couple of years.
SHL has a better Operating Margin (13.53%) than 63.49% of its industry peers.
In the last couple of years the Operating Margin of SHL has remained more or less at the same level.
Looking at the Gross Margin, with a value of 38.63%, SHL is doing worse than 77.78% of the companies in the same industry.
SHL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.53% | ||
| PM (TTM) | 9.17% | ||
| GM | 38.63% |
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SHL is creating some value.
SHL has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SHL has more shares outstanding
Compared to 1 year ago, SHL has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 1.99 indicates that SHL is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of SHL (1.99) is comparable to the rest of the industry.
The Debt to FCF ratio of SHL is 5.45, which is a neutral value as it means it would take SHL, 5.45 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.45, SHL is in line with its industry, outperforming 55.56% of the companies in the same industry.
A Debt/Equity ratio of 0.63 indicates that SHL is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.63, SHL is doing worse than 69.84% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 5.45 | ||
| Altman-Z | 1.99 |
ROIC/WACC1.21
WACC6.35%
2.3 Liquidity
SHL has a Current Ratio of 1.11. This is a normal value and indicates that SHL is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of SHL (1.11) is worse than 71.43% of its industry peers.
SHL has a Quick Ratio of 1.11. This is a bad value and indicates that SHL is not financially healthy enough and could expect problems in meeting its short term obligations.
SHL has a Quick ratio of 0.79. This is in the lower half of the industry: SHL underperforms 71.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
SHL shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.17%.
SHL shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.29% yearly.
Looking at the last year, SHL shows a small growth in Revenue. The Revenue has grown by 4.53% in the last year.
Measured over the past years, SHL shows a quite strong growth in Revenue. The Revenue has been growing by 10.08% on average per year.
EPS 1Y (TTM)7.17%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%1.49%
Revenue 1Y (TTM)4.53%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-0.11%
3.2 Future
The Earnings Per Share is expected to grow by 13.66% on average over the next years. This is quite good.
Based on estimates for the next years, SHL will show a small growth in Revenue. The Revenue will grow by 5.04% on average per year.
EPS Next Y6.78%
EPS Next 2Y9.66%
EPS Next 3Y11.45%
EPS Next 5Y13.66%
Revenue Next Year4.22%
Revenue Next 2Y5.11%
Revenue Next 3Y6.41%
Revenue Next 5Y5.04%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 17.79, the valuation of SHL can be described as rather expensive.
Based on the Price/Earnings ratio, SHL is valued cheaply inside the industry as 85.71% of the companies are valued more expensively.
SHL's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.98.
The Price/Forward Earnings ratio is 16.66, which indicates a correct valuation of SHL.
Based on the Price/Forward Earnings ratio, SHL is valued a bit cheaper than the industry average as 69.84% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 35.79. SHL is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.79 | ||
| Fwd PE | 16.66 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SHL is valued a bit cheaper than the industry average as 68.25% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, SHL is valued cheaper than 87.30% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.68 | ||
| EV/EBITDA | 13.35 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of SHL may justify a higher PE ratio.
PEG (NY)2.62
PEG (5Y)1.58
EPS Next 2Y9.66%
EPS Next 3Y11.45%
5. Dividend
5.1 Amount
SHL has a Yearly Dividend Yield of 2.30%.
SHL's Dividend Yield is rather good when compared to the industry average which is at 2.22. SHL pays more dividend than 80.95% of the companies in the same industry.
SHL's Dividend Yield is comparable with the S&P500 average which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.3% |
5.2 History
The dividend of SHL has a limited annual growth rate of 4.33%.
Dividend Growth(5Y)4.33%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
49.72% of the earnings are spent on dividend by SHL. This is a bit on the high side, but may be sustainable.
The dividend of SHL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP49.72%
EPS Next 2Y9.66%
EPS Next 3Y11.45%
FRA:SHL (11/25/2025, 5:36:15 PM)
42.53
+0.35 (+0.83%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners12.27%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap47.97B
Revenue(TTM)23.38B
Net Income(TTM)2.14B
Analysts82.96
Price Target57.22 (34.54%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.3% |
Yearly Dividend0.95
Dividend Growth(5Y)4.33%
DP49.72%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.69%
Min EPS beat(2)-3.98%
Max EPS beat(2)13.36%
EPS beat(4)2
Avg EPS beat(4)3.9%
Min EPS beat(4)-3.98%
Max EPS beat(4)13.36%
EPS beat(8)5
Avg EPS beat(8)4.19%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)10
Avg EPS beat(16)2.88%
Revenue beat(2)0
Avg Revenue beat(2)-2.43%
Min Revenue beat(2)-4.1%
Max Revenue beat(2)-0.77%
Revenue beat(4)2
Avg Revenue beat(4)-0.83%
Min Revenue beat(4)-4.1%
Max Revenue beat(4)1.29%
Revenue beat(8)2
Avg Revenue beat(8)-1.21%
Revenue beat(12)3
Avg Revenue beat(12)-0.98%
Revenue beat(16)7
Avg Revenue beat(16)-0.37%
PT rev (1m)-7.54%
PT rev (3m)-7.54%
EPS NQ rev (1m)-9.25%
EPS NQ rev (3m)-9.25%
EPS NY rev (1m)-2.35%
EPS NY rev (3m)-2.51%
Revenue NQ rev (1m)1.21%
Revenue NQ rev (3m)1.34%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-0.35%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.79 | ||
| Fwd PE | 16.66 | ||
| P/S | 2.05 | ||
| P/FCF | 17.68 | ||
| P/OCF | 13.58 | ||
| P/B | 2.66 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.35 |
EPS(TTM)2.39
EY5.62%
EPS(NY)2.55
Fwd EY6%
FCF(TTM)2.41
FCFY5.66%
OCF(TTM)3.13
OCFY7.36%
SpS20.72
BVpS15.99
TBVpS-4.95
PEG (NY)2.62
PEG (5Y)1.58
Graham Number29.33
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.83% | ||
| ROE | 11.88% | ||
| ROCE | 9.97% | ||
| ROIC | 7.65% | ||
| ROICexc | 8.31% | ||
| ROICexgc | 43.54% | ||
| OM | 13.53% | ||
| PM (TTM) | 9.17% | ||
| GM | 38.63% | ||
| FCFM | 11.61% |
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
ROICexc(3y)6.78%
ROICexc(5y)6.63%
ROICexgc(3y)34.62%
ROICexgc(5y)34.83%
ROCE(3y)8.18%
ROCE(5y)8.09%
ROICexgc growth 3Y13.77%
ROICexgc growth 5Y12.12%
ROICexc growth 3Y9.41%
ROICexc growth 5Y-1.08%
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
F-Score8
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 5.45 | ||
| Debt/EBITDA | 2.54 | ||
| Cap/Depr | 63.12% | ||
| Cap/Sales | 3.5% | ||
| Interest Coverage | 7.04 | ||
| Cash Conversion | 79.23% | ||
| Profit Quality | 126.59% | ||
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 1.99 |
F-Score8
WACC6.35%
ROIC/WACC1.21
Cap/Depr(3y)57.95%
Cap/Depr(5y)60.43%
Cap/Sales(3y)3.49%
Cap/Sales(5y)3.63%
Profit Quality(3y)107.05%
Profit Quality(5y)106.62%
High Growth Momentum
Growth
EPS 1Y (TTM)7.17%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%1.49%
EPS Next Y6.78%
EPS Next 2Y9.66%
EPS Next 3Y11.45%
EPS Next 5Y13.66%
Revenue 1Y (TTM)4.53%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-0.11%
Revenue Next Year4.22%
Revenue Next 2Y5.11%
Revenue Next 3Y6.41%
Revenue Next 5Y5.04%
EBIT growth 1Y12.53%
EBIT growth 3Y2.65%
EBIT growth 5Y10.19%
EBIT Next Year40.06%
EBIT Next 3Y18.71%
EBIT Next 5Y13.72%
FCF growth 1Y27.42%
FCF growth 3Y18%
FCF growth 5Y14.63%
OCF growth 1Y24.98%
OCF growth 3Y12.15%
OCF growth 5Y12.87%
SIEMENS HEALTHINEERS AG / SHL.DE FAQ
What is the fundamental rating for SHL stock?
ChartMill assigns a fundamental rating of 5 / 10 to SHL.DE.
What is the valuation status of SIEMENS HEALTHINEERS AG (SHL.DE) stock?
ChartMill assigns a valuation rating of 6 / 10 to SIEMENS HEALTHINEERS AG (SHL.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for SIEMENS HEALTHINEERS AG?
SIEMENS HEALTHINEERS AG (SHL.DE) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for SHL stock?
The Price/Earnings (PE) ratio for SIEMENS HEALTHINEERS AG (SHL.DE) is 17.79 and the Price/Book (PB) ratio is 2.66.
Can you provide the dividend sustainability for SHL stock?
The dividend rating of SIEMENS HEALTHINEERS AG (SHL.DE) is 6 / 10 and the dividend payout ratio is 49.72%.